Course overview:
Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.
Target audience:
This day–long course is open to clinicians (e.g. endocrinology, rheumatology, elderly care and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.
Objectives:
At the end of the course, participants should:
• understand the process of bone remodelling and how this can be studied using BTM
• appreciate the methods used for measuring BTM and their sources of variability
• be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, GIOP and PHPT.
• be familiar with best practice in the clinical use of BTM
Endorsement and CPD: Applications for CPD will be submitted to the Czech and Slovak national bodies.